Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sandy Charlton"'
Publikováno v:
Circulation. 142
Introduction: Amiodarone is the most effective drug for the treatment of atrial fibrillation (AF), but long-term administration of standard doses can have prohibitive side effects. Little data is available for use of lower doses. We sought to determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e03e3b4dd13a6434eca3c2a089d034f0
https://doi.org/10.1161/circ.142.suppl_3.16468
https://doi.org/10.1161/circ.142.suppl_3.16468
Publikováno v:
Circulation. 142
Introduction: Our previous work has shown low-dose Amiodarone (often less than 600 mg per week) is effective for control of AF in a forced down-titration schema. Many studies have shown restoration of sinus rhythm in patients with CHF shows promise f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfcbabbd634736414103b50912b0f217
https://doi.org/10.1161/circ.142.suppl_3.16548
https://doi.org/10.1161/circ.142.suppl_3.16548
Autor:
Likhitesh Jaikumar, Sandy Charlton, Anju Priyadarshini, Barry Flannery, Frank A. McGrew, William G. Stevenson
Publikováno v:
Journal of the American College of Cardiology. 79:2491
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8ce093f64f7c11dbae54f821b78a367
https://doi.org/10.1016/s0735-1097(22)03482-9
https://doi.org/10.1016/s0735-1097(22)03482-9
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b83c4cb20dce50e7e5675d610b748862
https://doi.org/10.1093/eurheartj/ehy566.p5764
https://doi.org/10.1093/eurheartj/ehy566.p5764
Publikováno v:
Journal of Cardiac Failure. 25:S122
Background Micra transcatheter pacing systems were first brought onto the market in 2016. Currently the Micra pacemaker is indicated for VVIR mode in patients that experience symptomatic high-grade AV block, tachy-brady syndrome and individuals consi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc43af00e0caafc3af8ba60c32f07156
https://doi.org/10.1016/j.cardfail.2019.07.349
https://doi.org/10.1016/j.cardfail.2019.07.349
Publikováno v:
Journal of the American College of Cardiology. 69:372
Background: Amiodarone is the most effective antiarrhythmic agent for the treatment of atrial fibrillation (AF) but its use is limited by side effects related to the cumulative drug exposure. Protocol driven down titration is not commonly employed. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f28dfb254f4a1fdf7299a605ce5d3c01
https://doi.org/10.1016/s0735-1097(17)33761-0
https://doi.org/10.1016/s0735-1097(17)33761-0